Unity Biotechnology, Inc. Appoints Przemyslaw Sapieha as Chief Scientific Advisor
February 01, 2021 at 06:30 pm IST
Unity Biotechnology, Inc. announced the appointment of Przemyslaw (Mike) Sapieha, Ph.D., as chief scientific advisor. As the Wolfe Professor of Translational Research at the University of Montreal and director of the neurovascular eye disease research unit at Hôpital Maisonneuve-Rosemont in Montreal, Dr. Sapieha has made seminal contributions to the understanding of ophthalmologic diseases.